AMN Healthcare Services Valuation
Is AMN * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of AMN * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: AMN * (MX$1293) is trading below our estimate of fair value (MX$4936.13)
Significantly Below Fair Value: AMN * is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for AMN *?
Key metric: As AMN * is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is AMN *'s PE Ratio? | |
|---|---|
| PE Ratio | 10.3x |
| Earnings | US$210.68m |
| Market Cap | US$2.17b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.9x |
| Enterprise Value/EBITDA | 6.9x |
| PEG Ratio | 1.5x |
Price to Earnings Ratio vs Peers
How does AMN *'s PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 92.7x | ||
ADUS Addus HomeCare | 28.8x | 19.1% | US$2.1b |
MCOV B Medicover | 114.2x | 40.9% | SEK 26.2b |
ASTH Astrana Health | 31.9x | 20.3% | US$2.0b |
PRVA Privia Health Group | 196x | 39.0% | US$2.5b |
AMN * AMN Healthcare Services | 10.3x | 6.7% | Mex$2.2b |
Price-To-Earnings vs Peers: AMN * is good value based on its Price-To-Earnings Ratio (10.3x) compared to the peer average (64.5x).
Price to Earnings Ratio vs Industry
How does AMN *'s PE Ratio compare vs other companies in the Global Healthcare Industry?
| 11 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 11 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Earnings vs Industry: AMN * is good value based on its Price-To-Earnings Ratio (10.3x) compared to the Global Healthcare industry average (21.8x).
Price to Earnings Ratio vs Fair Ratio
What is AMN *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 10.3x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate AMN *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Médica Sur. de
Mex$3.1b
Operates as a healthcare hospital in Mexico.
MEDICA B
Mex$28.84
7D
3.0%
1Y
-30.8%
Teladoc Health
US$1.6b
Provides virtual healthcare services worldwide.
TDOC *
US$183.00
7D
-10.7%
1Y
-36.9%
ZimVie
US$186.2m
Develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide.
ZIMV *
US$230.00
7D
0%
1Y
n/a